skip to main content

ProfessionalsLaura C. Turano

Laura C. Turano

Tel: +1-212-373-3659
Fax: +1-212-492-0659

Tel: +1-212-373-3659
New York

1285 Avenue of the Americas
New York, NY 10019-6064
Fax: +1-212-492-0659

Bar Admissions 
Bar Admissions 

Laura C. Turano is a partner in the Corporate Department and a member of the firm’s Mergers & Acquisitions Group. Laura’s practice focuses on advising clients in connection with public and private company mergers and acquisitions, joint ventures, carve-outs and other significant transactions. She also advises clients on activist defense and corporate governance matters. Laura is a member of the Advisory Counsel of the NYU Law Institute for Corporate Governance & Finance and is an adjunct professor at NYU School of Law teaching mergers & acquisitions. Laura was also Chair of the Women in Law Empowerment Forum (WILEF) East Young Lawyers Committee.


In 2024, Laura was recognized as a finalist in IFLR Europe’s “IFLR Women Dealmakers Hall of Fame.” In 2023, Laura was named to Crain’s New York Business’ "40 under 40” and “Notable Women in Law”, recognized as a “U.S. Rising Star – Financial & Corporate” by LMG Life Sciences, an “MVP” in M&A by Law360 and as one of the “500 Leading Dealmakers in America” by Lawdragon. In 2022, Laura was recognized by Bloomberg Law in its “They’ve Got Next: 40 Under 40”, a finalist in American Lawyer’s Industry Awards for “Young Lawyer of the Year”, one of the “Top Women in Dealmaking” by The Deal, a “Rising Star” in M&A by Law360 and as one of the “500 Leading Dealmakers in America” by Lawdragon. In 2021, The American Lawyer named her “Dealmaker of The Year” for her role advising Teladoc Health in its acquisition of Livongo Health. Laura is also recognized in The Legal 500 for her work in Corporate/M&A.


Laura’s notable representations have included:

  • 3G Capital in its $7.1 billion acquisition of Hunter Douglas
  • ABB in its $2.6 billion acquisition of General Electric’s Industrial Solutions business
  • AstraZeneca in its $2.7 billion acquisition of ZS Pharma
  • Baker Hughes in its proposed $38 billion merger with Halliburton; the formation of its hydraulic-fracturing joint venture with CSL Capital and West Street Energy Partners; its $32 billion merger with GE Oil & Gas and GE’s subsequent sell-down of its majority stake in Baker Hughes; and the formation of its global offshore drilling joint venture with Akastor
  • Carrier Global Corporation in its €12 billion acquisition of Viessmann Climate Solutions; its $4.95 billion sale of its global access solutions business to Honeywell; its $3.1 billion sale of its Chubb fire and security business to APi Group Corporation; its $1.425 billion sale of its Industrial Fire business to Sentinel Capital Partners; and the sale of its global commercial refrigeration business to Haier
  • Chico’s FAS in its $1 billion sale to Sycamore Partners
  • CNOOC in its $17.9 billion acquisition of Nexen
  • CSX in its settlement agreement with Mantle Ridge
  • The special committee of Duck Creek Technologies’ board of directors in connection with Duck Creek’s $2.6 billion take-private sale to Vista Equity Partners
  • The Estée Lauder Companies in its $2.8 billion acquisition of the Tom Ford brand
  • ExxonMobil in its $2.5 billion acquisition of InterOil
  • Goldman Sachs Merchant Banking Division in its acquisition of Boyd Corporation
  • IBM in its spin-off of its managed infrastructure services business into a separate publicly traded company and its $4.6 billion acquisition of Apptio
  • IG Group Holdings in its $1 billion acquisition of tastytrade
  • Intel Corporation in the activist investment by Third Point
  • John Wood Group in its $1.9 billion sale of its Built Environment consulting business to WSP Global
  • The special committee of the board of directors of Madison Square Garden Entertainment in the spin-off of its traditional live entertainment businesses, to create a new publicly traded company known as Sphere Entertainment Co.
  • Merck & Co. in its $11.5 billion acquisition of Acceleron Pharma and its $10.8 billion acquisition of Prometheus Biosciences
  • Mitsubishi UFJ Lease & Finance in the $1.3 billion acquisition of Jackson Square Aviation and acquisitions of Engine Lease Finance Corp. and Beacon Intermodal Leasing
  • Mizuho Financial Group in its acquisition of Greenhill & Co.
  • PharMerica in its approximately $1.4 billion sale to KKR
  • PRA Health Sciences in its approximately $12 billion sale to ICON
  • Restaurant Brands International in its $1 billion acquisition of Firehouse Restaurant Group and its $1 billion acquisition of Carrols Restaurant Group 
  • Rocket Companies in its $1.275 billion acquisition of Truebill
  • Shawn “JAY-Z” Carter in connection with a long-term agreement that renews their partnership with D’USSE
  • SS&C in its acquisition of Citigroup’s Alternative Investor Services business
  • Teladoc Health in its $18.5 billion merger with Livongo Health
  • VF Corp. in the sale of the Nautica brand to Authentic Brands Group
  • WestRock in its $20 billion combination with Smurfit Kappa, creating Smurfit WestRock
  • Williams Partners in the $1.125 billion sale of its Four Corners Area business to Harvest Midstream and the sale of its 50% interest in Jackalope Gas Gathering Services to Crestwood Equity Partners

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy